학술논문
Neratinib as Extended Adjuvant Treatment of HER2-Positive/HR-Positive Early Breast Cancer Patients in Germany, Austria, and Switzerland: Interim Results of the Prospective, Observational ELEANOR Study
Document Type
Article
Author
Source
In: Breast Care . (Breast Care, 1 February 2024, 19(1):1-9)
Subject
Language
English
ISSN
16613805
16613791
16613791